{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 47.61,
  "market_cap": 211554058240,
  "revenue_ttm": 49528495091.92345,
  "net_income_ttm": 16285398178.008991,
  "ocf_ttm": 19425782506.689262,
  "capex_ttm": 9860722048.288254,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1393407248.7308052,
  "total_debt": 15883806878.369152,
  "cash_and_equivalents": 5113344789.435277,
  "book_value_ttm": 26662272545.373222,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4664044,
  "dividend_yield": 361.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-19T01:28:41Z"
}